Canada approves AstraZeneca COVID-19 vaccine |
Clinical News
eMediNexus Coverage from: 
Canada approves AstraZeneca COVID-19 vaccine

1 Read Comments                

Canada has granted approval for the AstraZeneca COVID-19 vaccine, including the one produced by the Serum Institute of India. Overall, 500,000 doses of the vaccine are expected to arrive in the country next week.

This is the third vaccine to be approved by Health Canada after the approval of vaccines developed by Pfizer-BioNTech and Moderna in December. Prime Minister Justin Trudeau stated that with the three vaccines, the country will now get over 6.5 million doses before March end. Additionally, tens of millions of more doses will reach between April and June. Twenty million doses have been ordered by Canada from AstraZeneca, of which 1.9 million will be received through COVAX in the first half of this year… (Reuters, February 26, 2021)
To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now